Eksempler på bruk av To insufficient data på Engelsk og deres oversettelse til Norsk
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Unable to create Data-Driven model due to insufficient data.
Due to insufficient data, is not recommended to take the medication during pregnancy and lactation.
In patients with CLCR<30 ml/min use is not recommended due to insufficient data.
For health related quality of life: Due to insufficient data we did not perform a network meta-analysis for health related quality of life.
Dosing recommendations for paediatric patients cannot be made due to insufficient data(see section 4.2).
If you have enabled Data-Driven Attribution but don't meet this threshold,you will see a notification in the Attribution reports alerting you that a Data-Driven model can't be generated due to insufficient data.
Arzerra is not recommended for use in children below 18 years due to insufficient data on safety and/or efficacy.
For one or more of your selected conversions,a Data-Driven model couldn't be generated due to insufficient data.
The potential need for dose adjustment in patients with severe renal impairment cannot be determined due to insufficient data and therefore patients with severe renal impairment should be monitored carefully.
CLCR< 30 ml/min: use is not recommended in patients with severe renal impairment due to insufficient data.
ABILIFY is not recommended for use in patients with schizophrenia below 15 years of age due to insufficient data on safety and efficacy(see sections 4.8 and 5.1).
Paediatric patients: Pylobactell is not recommended for use in children and adolescents below the age of 18 years due to insufficient data on efficacy.
TachoSil is not recommended for use in children below age 18 years due to insufficient data on safety and efficacy.
IDflu is not recommended for use in children andadolescents below 18 years due to insufficient data on safety and efficacy.
Pylobactell is not recommended for use in children below the age of 18 years due to insufficient data on efficacy.
AUBAGIO should be used with caution in patients aged 65 years and over due to insufficient data on safety and efficacy.
Tasmar is not recommended for use in children below the age of 18 due to insufficient data on safety or efficacy.
Revolade is not recommended for use in children under the age of one year with chronic ITP due to insufficient data on safety and efficacy.
SOMAC Control is not recommended for use in children andadolescents below 18 years of age due to insufficient data on safety and efficacy.
Revatio solution for injection is not recommended for use in children below 18 years due to insufficient data on safety and efficacy.
Due to insufficient clinical data.